Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-05-28

Clinical Trial Update: Chronic Hepatitis C (CHC) - Genotype 3 Infection in Canada

View source ↗

Summary

A clinical trial studying chronic hepatitis C genotype 3 infection in Canada has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Health Network, Toronto | Conditions: Chronic Hepatitis C - Genotype 3 | Status: TERMINATED